Apr 07, 2022 / Transcripts April 2022 meeting transcript Research Areas: Ambulatory Care Settings, Drugs, Devices, and Tests, Medicare Spending and Financing, Quality
Mar 15, 2022 / Press Releases MedPAC releases March 2022 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Mar 15, 2022 / Reports March 2022 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Mar 15, 2022 / Chapters Executive Summary (March 2022 Report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Mar 15, 2022 / Chapters Chapter 13: The Medicare prescription drug program (Part D): Status report (March 2022 Report) Research Areas: Drugs, Devices, and Tests, Quality
Mar 15, 2022 / Chapters Appendix A: Commissioners’ voting on recommendations (March 2022 Report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Mar 04, 2022 / Comment Letters MedPAC comment on CMS’s notice of proposed rulemaking on contract year 2023 policy and technical changes to Medicare Advantage and Part D Research Areas: Drugs, Devices, and Tests, Private Plans
Mar 03, 2022 / Presentations Medicare payment policies to support safety-net providers Research Areas: Hospitals
Feb 02, 2022 / Congressional Testimony Testimony: The Hospital Insurance Trust Fund and the Future of Medicare Financing (Senate Finance) Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans, Quality
Jan 14, 2022 / Presentations The Medicare prescription drug program (Part D): Status report Research Areas: Drugs, Devices, and Tests, Private Plans